• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

biosimilar

Novartis Sandoz
Manufacturing

Sandoz pumps $440M into another Slovenia biosimilar plant

The latest project will bring Sandoz' total planned and ongoing investments in Slovenia to more than $1.1 billion by 2029.
Zoey Becker Jul 2, 2025 9:10am
layoffs job cuts fired exit restructuring layoff reduction

Coherus loses commercial chief amid exit from biosimilar space

Apr 23, 2025 11:19am
scales of justice court legal law

Health plan sues AZ's Alexion over 'fraudulent' Soliris patents

Apr 17, 2025 10:50am
GoodRx

Sanofi gains FDA nod for first biosimilar version of NovoLog

Feb 18, 2025 11:05am
Pills with dollars

IRA biosim policy plays 'small' role in savings so far: report

Aug 29, 2024 1:35pm
Boehringer Ingelheim Boehringer

BI taps GoodRx to offer its Humira biosim at a steep markdown

Jul 18, 2024 11:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings